Private Advisor Group, LLC Sesen Bio, Inc. Transaction History

Private Advisor Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$0.77 - $4.91 $785 - $5,008	-1,020 Reduced 9.26%	10,000 $8,000
Q2 2021 Aug 12, 2021	SELL	$2.18 - $4.66 $5,406 - $11,556	-2,480 Reduced 18.37%	11,020 $51,000
Q1 2021 Apr 22, 2021	SELL	$1.3 - $3.24 $52,650 - $131,220	-40,500 Reduced 75.0%	13,500 $35,000
Q3 2020 Nov 02, 2020	BUY	$0.67 - $1.4 $13,400 - $28,000	20,000 Added 58.82%	54,000 $76,000
Q4 2019 Feb 10, 2020	BUY	$0.89 - $1.5 $13,350 - $22,500	15,000 Added 78.95%	34,000 $35,000
Q2 2019 Aug 14, 2019	SELL	$0.95 - $2.46 $37,452 - $96,983	-39,424 Reduced 67.48%	19,000 $29,000
Q1 2019 May 13, 2019	BUY	$0.69 - $1.47 $40,312 - $85,883	58,424 New	58,424 $60,000
Q4 2018 Feb 11, 2019	SELL	$0.96 - $2.04 $23,543 - $50,028	-24,524 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$1.54 - $2.38 $37,766 - $58,367	24,524 New	24,524 $53,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.